Lineage Cell Therapeutics, Inc.· LCTX

🇺🇸 US · MicroBroad USAMEX

HealthcareBiotechnologyWebsite

Price: $1.12
Day: +0.90%
Mkt Cap: $279.21M
52W Range: $0.95 – $2.09
Volume: 695.7K
Beta: 1.55

D25D FrameworkTTM Data

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Blog

stockoscope.com

Lineage Cell Therapeutics, Inc.

LCTX|Healthcare|Biotechnology

Comparing against 163 sector peers in United States · Micro Cap · Healthcare

Peer Comparison

Dimension 2 of 5

Revenue Growth

86%ile

54.6%

Operating Margin

N/A

ROIC

47%ile

-34.1%

FCF Yield

71%ile

-8.0%

Growth & Cash Flow Quality

Percentile ranking across profitability growth and cash generation

EBITDA Growth

177.1%

EBIT Growth

171.3%

Net Income Growth

296.2%

OCF Growth

-0.4%

FCF Growth

-1.4%

Income Quality

0.35

Returns on Capital (TTM)

ROE(-152.1%)

13%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROCE(-37.2%)

45%ile

Average

PoorWeakAdequateStrongExceptional

ROA(-58.6%)

13%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROIC(-34.1%)

47%ile

Average

PoorWeakAdequateStrongExceptional

Profit Margins (TTM)

Gross Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

EBITDA Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Operating Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Net Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Leverage & Coverage (TTM)

Debt/Equity

78%ile

0.02

Debt/Capital

76%ile

0.02

Net Debt/EBITDA

64%ile

0.78

Interest Coverage

N/A

Liquidity (TTM)

Current Ratio

62%ile

6.89

Quick Ratio

64%ile

6.89

Cash Ratio

76%ile

4.41

WC Turnover

51%ile

0.31

Operational Efficiency (TTM)

Asset Turnover

29%ile

0.13

DSO

60%ile

19.9

Days Inventory

73%ile

0.00

Cash Conv. Cycle

N/A

TTM: Trailing Twelve Months · EBITDA: Earnings Before Interest, Taxes, Depreciation & Amortization · EBIT: Earnings Before Interest & Taxes · ROA: Return on Assets · ROIC: Return on Invested Capital · ROCE: Return on Capital Employed · ROE: Return on Equity · OCF: Operating Cash Flow · FCF: Free Cash Flow · DSO: Days Sales Outstanding · WC: Working Capital

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore LCTX on stockoscope.com→

Generated August 5, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

163 sector peers (United States · Micro Cap · Healthcare)

Relative Quality

LCTX Relative Quality Score

Ranked against 163 sector peers in United States · Micro Cap · Healthcare

Relative Quality

3.1/5

Adequate

vs 163 sector peers

Peer Rankings (9 of 10 available)

Relative Quality Score of 3.13/5 (Adequate) based on percentile rankings against 163 sector peers in United States · Micro Cap · Healthcare. Each pillar shows a 1-5 score plus the cohort percentile (e.g. 95p = top 5%); higher percentiles indicate stronger relative performance.Last updated August 4, 2026.

Top-Line and Profit Growth

How does the company's growth rate compare to peers?

Revenue Growth

86th percentile, Exceptional

Value: 54.64%
Percentile: 86%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

LCTX has a ttm revenue growth of 54.64% and ranks at the 86th percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Margin Efficiency

Does the company maintain better profit margins than peers?

No data for Gross Margin is available for LCTX, so peer comparison is hidden for this metric. Try another metric.

Operational Efficiency

Is the company more operationally efficient than competitors?

Asset Turnover

29th percentile, Weak

Value: 0.13
Percentile: 29%
Score: 2/5

PoorWeakAdequateStrongExceptional

Analysis

LCTX has a ttm asset turnover of 0.13 and ranks at the 29th percentile vs United States · Healthcare sector peers. Below average financial performance.

Returns Overview

Does the company generate better returns on capital than peers?

ROA

13th percentile, Poor

Value: -58.62%
Percentile: 13%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

LCTX has a ttm roa of -58.62% and ranks at the 13th percentile vs United States · Healthcare sector peers. Poor financial performance.

Cash Flow Quality

How does the company's cash generation compare to peers?

Operating Cash Flow Growth

52nd percentile, Adequate

Value: -0.38%
Percentile: 52%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

LCTX has a ttm operating cash flow growth of -0.38% and ranks at the 52nd percentile vs United States · Healthcare sector peers. Adequate financial performance.

Liquidity and Working Capital

Does the company maintain better liquidity positions than competitors?

Cash Ratio

76th percentile, Strong

Value: 4.41
Percentile: 76%
Score: 4/5

PoorWeakAdequateStrongExceptional

Analysis

LCTX has a ttm cash ratio of 4.41 and ranks at the 76th percentile vs United States · Healthcare sector peers. Strong financial performance.

Leverage and Coverage

Is the company's debt burden more manageable than peers?

Debt to Capital

76th percentile, Strong

Value: 0.02
Percentile: 76%
Score: 4/5

PoorWeakAdequateStrongExceptional

Analysis

LCTX has a ttm debt-to-capital of 0.02 and ranks at the 76th percentile vs United States · Healthcare sector peers. Strong financial performance.

Valuation Multiples

Is the company's stock valuation attractive relative to peers?

P / E Ratio

Insufficient peer data

Value: -4.06
Percentile: n/a
Score: n/a

PoorWeakAdequateStrongExceptional

Analysis

Not enough peer data to rank LCTX for ttm p/e ratio in this cohort.

Dividend and Shareholder Yield

Does the company deliver superior income to shareholders compared to peers?

Dividend Yield

41st percentile, Adequate

Value: 0.00%
Percentile: 41%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

LCTX has a ttm dividend yield of 0.00% and ranks at the 41st percentile vs United States · Healthcare sector peers. Adequate financial performance.

Peer companies

The 162 companies LCTX is compared against across its sector and industry cohorts.

Lineage Cell Therapeutics, Inc.· LCTX

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies

Search stocks

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies